Document is current
Any future updates will be listed below
-
Authors
Tokolyi, Alex https://orcid.org/0000-0003-4222-7484
Persyn, Elodie https://orcid.org/0000-0001-9104-1972
Nath, Artika P.
Burnham, Katie L. https://orcid.org/0000-0001-8680-2933
Marten, Jonathan
Vanderstichele, Thomas
Tardaguila, Manuel https://orcid.org/0000-0001-7812-604X
Stacey, David https://orcid.org/0000-0002-9392-9235
Farr, Ben
Iyer, Vivek
Jiang, Xilin https://orcid.org/0000-0001-6773-9182
Lambert, Samuel A.
Noell, Guillaume
Quail, Michael A. https://orcid.org/0000-0002-3861-0483
Rajan, Diana
Ritchie, Scott C. https://orcid.org/0000-0002-8454-9548
Sun, Benjamin B. https://orcid.org/0000-0001-6347-2281
Thurston, Scott A. J. https://orcid.org/0000-0002-1657-9200
Xu, Yu https://orcid.org/0000-0002-7304-5045
Whelan, Christopher D. https://orcid.org/0000-0003-0308-5583
Runz, Heiko
Petrovski, Slavé https://orcid.org/0000-0002-1527-961X
Gaffney, Daniel J.
Roberts, David J.
Di Angelantonio, Emanuele https://orcid.org/0000-0001-8776-6719
Peters, James E. https://orcid.org/0000-0002-9415-3440
Soranzo, Nicole
Danesh, John
Butterworth, Adam S. https://orcid.org/0000-0002-6915-9015
Inouye, Michael https://orcid.org/0000-0001-9413-6520
Davenport, Emma E.
Paul, Dirk S. https://orcid.org/0000-0002-8230-0116
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 22 January 2025
First Online: 4 March 2025
Competing interests
: M.A.Q. is on the Key Opinion Leader panel for New England Biolabs. B.B.S. and H.R. are employees and stockholders of Biogen. C.D.W. is an employee and stockholder of Johnson & Johnson. S.P. and D.S.P. are employees and stockholders of AstraZeneca. D.J.G. is an employee and stockholder of BioMarin Pharmaceutical. D.J.R. is an employee of NHSBT. J.E.P. has received hospitality and travel expenses to speak at Olink-sponsored academic meetings (none within the past 5 years). A.S.B. has received grants outside of this work from AstraZeneca, Bayer, Biogen, BioMarin and Sanofi. M.I. is a trustee of the Public Health Genomics Foundation, a member of the Scientific Advisory Board of Open Targets and has a research collaboration with AstraZeneca that is unrelated to this study. The other authors declare no competing interests.
